
Aktiviere Job-Benachrichtigungen per E-Mail!
Erstelle in nur wenigen Minuten einen maßgeschneiderten Lebenslauf
Überzeuge Recruiter und verdiene mehr Geld. Mehr erfahren
A major healthcare center in Germany seeks a Postdoctoral Researcher to join their Department of Neuropathology. This role focuses on analyzing spatial transcriptomics data to improve diagnostic tools related to brain tumours. Candidates should possess a PhD in Bioinformatics or related fields and have experience in multi-omics data analysis. This full-time position offers a unique opportunity for professional development in a collaborative research environment.
The University Hospital Heidelberg is one of the major healthcare centers in Germany. Our objective is the development of innovative diagnostics and therapies as well as their quick implementation for the patient. With about 14,000 employees in more than 50 specialized clinical departments with almost 2,500 beds, about 80,000 patients in part‑time and full‑time inpatient treatment as well as 1,000,000 patients in ambulant treatment are medicated each year.
wanted of the next possible date at Department of Neuropathology at the University Hospital Heidelberg.
We are a DFG‑funded research group within the Department of Neuropathology at the University Hospital Heidelberg. Our work focuses on understanding brain tumour biology and developing innovative diagnostic tools to improve patient care. These efforts are enabled by our department's world‑leading collection of brain tumour samples which are complemented by DNA methylation, DNA and RNA sequencing as well as clinical data.
Together with the Artificial Intelligence and Cancer Evolution Division at the German Cancer Research Centre DKFZ, led by Moritz Gerstung, we have recently established a systematic spatial transcriptomics programme to gain deeper insights into how different types of brain tumours grow and how brain tumour and brain resident cells interact in this process.
You will contribute to these research efforts by analysing spatial transcriptomics data from hundreds of brain tumours to establish the molecular underpinnings of tumour growth patterns and the cellular interactions enabling malignancy. The integration with available methylation, histopathological and clinical data will help establish links to current diagnostic procedures and facilitate the rapid translation of your findings. You will be co‑supervised by Abigail Suwala and Moritz Gerstung, offering a unique opportunity to further develop your skills at the intersection of AI and translational neuropathology.
The contract is initially limited to 2 years with the possibility of an extension. You will benefit from excellent core facilities as well as a dynamic and creative interdisciplinary research atmosphere.
For further information please contact Dr. Abigail Suwala via e‑mail.
Interested?
Applications will be accepted directly online.
Neuropathologie
Dr. med. Abigail Suwala – Emmy‑Noether group leader and physician
Im Neuenheimer Feld 224
69120 Heidelberg
Abigail.suwala@med.uni-heidelberg.de
Note: The UKHD is subject to the provisions of the Infektionsschutzgesetz. Therefore, a valid measles immunity certificate is required for all persons employed at the UKHD.
The UKHD embraces diversity and values diversity.
Regardless of age, gender, sexual identity, disability, origin or religion, we offer everyone the same opportunities. If one gender is underrepresented in a particular area, we place particular emphasis on counteracting this imbalance. If they have the same aptitude, qualifications and professional performance, we give priority to people with severe disabilities when considering them for vacancies.
Classification is based on qualifications and personal requirements. The salary (gross) is for a full‑time position and does not include the annual bonus or other allowances.